SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001570562-23-000070
Filing Date
2023-05-09
Accepted
2023-05-09 17:12:25
Documents
63
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q eols-20230331.htm   iXBRL 10-Q 1403205
2 EX-31.1 exhibit311q12023.htm EX-31.1 10694
3 EX-31.2 exhibit312q12023.htm EX-31.2 10681
4 EX-32.1 exhibit321q12023.htm EX-32.1 7797
  Complete submission text file 0001570562-23-000070.txt   6487422

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT eols-20230331.xsd EX-101.SCH 40718
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT eols-20230331_cal.xml EX-101.CAL 69648
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT eols-20230331_def.xml EX-101.DEF 228026
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT eols-20230331_lab.xml EX-101.LAB 576090
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT eols-20230331_pre.xml EX-101.PRE 380325
57 EXTRACTED XBRL INSTANCE DOCUMENT eols-20230331_htm.xml XML 882740
Mailing Address 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH CA 92660
Business Address 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH CA 92660 (949) 284-4555
Evolus, Inc. (Filer) CIK: 0001570562 (see all company filings)

IRS No.: 461385614 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38381 | Film No.: 23903329
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences